---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-038851"
form_type: "8-K"
ticker: "ARMP"
cik: "0000921114"
company_name: "Armata Pharmaceuticals, Inc."
filed_at: "2022-03-28T23:59:59+00:00"
generated_at: "2026-06-26T16:55:43.472255+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Armata CFO Steve Martin to retire June 30; Erin Butler named successor as CFO & VP Finance

## Summary
- CFO Steve R. Martin to retire effective June 30, 2022; will serve as advisor through Dec 31, 2022.
- Martin to receive continued base salary ($389,340/yr) during transition; half of unvested options to vest at end.
- Erin Butler appointed VP Finance & Admin (April 1) and Principal Financial & Accounting Officer (July 1).
- Butler's compensation: $290K base salary, 30% target bonus, option for 50,000 shares vesting over 4 years.
- Butler to get 6 months severance on involuntary termination; full equity acceleration on change in control.

## SEC filing metadata
- accession: 0001104659-22-038851
- form_type: 8-K
- ticker: ARMP
- cik: 0000921114
- company_name: Armata Pharmaceuticals, Inc.
- filed_at: 2022-03-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/921114/000110465922038851/0001104659-22-038851-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/921114/000110465922038851/tm2210607d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-038851
- JSON: https://secwatch.observer/filing/0001104659-22-038851.json
- Plain text: https://secwatch.observer/filing/0001104659-22-038851.txt

## Key facts
- Executive change
  Steve R. Martin departed as Chief Financial Officer and Senior Vice President at Armata Pharmaceuticals, Inc..
  - Action: retire
  - Role: Chief Financial Officer and Senior Vice President
  source text: On March 25, 2022, Steve R. Martin notified Armata Pharmaceuticals, Inc. (the “Company”) that he intends to retire as Chief Financial Officer and Senior Vice President (and Principal Financial and Accounting Officer) of the Company effective as of June 30, 2022 (the “Transition Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/921114/000110465922038851/0001104659-22-038851-index.htm
- Executive change
  Erin Butler was appointed as Vice President of Finance and Administration and Principal Financial and Accounting Officer at Armata Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Vice President of Finance and Administration and Principal Financial and Accounting Officer
  source text: On March 25, 2022, the Board appointed Erin Butler to serve as (i) Vice President of Finance and Administration of the Company, effective April 1, 2022, and (ii) Principal Financial and Accounting Officer of the Company, effective July 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/921114/000110465922038851/0001104659-22-038851-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.